It's time to recognize excellence! The ATTD Breakthrough Outcomes Award, supported by Lilly, honors innovation in clinical practice for people with Type 2 Diabetes. Join us in celebrating advancements in #DiabetesCare during the closing ceremony! #ATTD2025
Lilly Diabetes International
Pharmaceutical Manufacturing
Channel for the Professional Diabetes Community. Follow us for useful Diabetes related info.
About us
Lilly unites caring with discovery to make life better for people around the world.
When you engage with Lilly on LinkedIn (and any other of Lilly’s social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn.
- Website
-
https://e.lilly/3Rg4GSW
External link for Lilly Diabetes International
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
Updates
-
We are proud to support the diaTribe Foundation panel discussion at #ATTD2025. Join us Friday at 7:00PM in Hall B (Emerald Room) to learn about the role of technology, patient-centered interactions, and comprehensive and collaborative #DiabetesCare approaches.
-
-
Lilly looks forward to take part in the #ATTD2025 congress, where healthcare professionals, researchers, and industry experts come together to discuss the latest advancements in #DiabetesCare.
-
-
Are you attending #ATTD2025 this year? Meet us at the Lilly booth to discover how we’re advancing #DiabetesCare.
-
-
Discover the 4 key components of holistic care that the ADA/EASD consensus report emphasizes as the Goals of #DiabetesCare.¹ Follow us for more insights!
-
Ready to explore the latest in diabetes management? The Advanced Technologies & Treatment for Diabetes #ATTD2025 Congress is just days away! Connect with healthcare professionals, scientific experts, and innovators shaping the future of #DiabetesCare.
-
-
#DiabetesCare requires a multifactorial and holistic approach that goes beyond simply meeting HbA1c targets.¹,² Don’t miss out on more insights—follow us!
-
-
Addressing excess weight early helps achieve early glycemic control and is associated with reducing long-term risks.¹⁻³ Early intensive glycemic control (HbA1c <7%) makes a lasting difference for patients with #T2D. ²,³ 👉 Follow us for more insights.
-
-
In patients with #Diabetes, early intervention and attainment of glycemic control is associated with long-term benefits.¹⁻³ Stay informed—follow us for more!
-